CMR Imaging Techniques for Heart Disease
(Myomapping Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests new Cardiac Magnetic Resonance (CMR) imaging techniques to determine if they can better diagnose and treat heart problems such as ischemic heart disease, cardiomyopathies (heart muscle diseases), and myocarditis (heart inflammation). The goal is to make heart scans faster and more useful for doctors and patients. Individuals diagnosed with heart issues or who suspect they have one and are already scheduled for a heart MRI might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to advancements in heart imaging technology that could enhance future diagnostics and treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these CMR imaging techniques are safe for heart disease patients?
Research has shown that Cardiac Magnetic Resonance (CMR) imaging is generally safe for most people. It produces detailed images of the heart without harmful radiation, making it a preferred method for examining heart issues.
Studies have found that CMR is safe for individuals without metal devices in their bodies. For those with devices like pacemakers, special safety measures are necessary, but the procedure can still be performed safely.
Overall, CMR is a well-tolerated and safe option for assessing heart health.12345Why are researchers excited about this trial?
Researchers are excited about new CMR imaging techniques for heart disease because they could dramatically cut down the time needed for scans. Unlike current imaging options, which often take longer and might require more patient cooperation, these faster MR scans aim to streamline the process without losing accuracy. This advancement could mean quicker diagnoses and more efficient management of heart conditions, benefiting both patients and healthcare providers.
What evidence suggests that CMR imaging techniques are effective for heart disease?
Research has shown that Cardiac Magnetic Resonance (CMR) imaging is a powerful tool for diagnosing heart problems. In one study, CMR influenced treatment decisions for 71% of patients with heart issues. Another study found CMR to be very accurate for individuals suspected of having coronary artery disease. This imaging method is considered the best for assessing heart function. CMR is highly valued for its ability to diagnose and assess heart diseases, even though it isn't used as often as some other methods. Overall, CMR shows strong promise in helping doctors better understand and treat heart diseases. Participants in this trial will undergo an additional 5-minute research MR scan of the heart to evaluate new, faster MR scans.46789
Who Is on the Research Team?
Akos Varga-Szemes, MD
Principal Investigator
Medical University of South Carolina
Are You a Good Fit for This Trial?
This trial is for adults aged 18-90 with suspected or diagnosed heart conditions like ischemic heart disease, hypertrophic cardiomyopathy, infiltrative cardiomyopathy, or myocarditis. They must be referred for a CMR scan and can't participate if they have metal implants, acute psychiatric disorders, substance abuse issues, allergies to MRI contrast agents, are in an unstable condition or won't follow the study rules.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo fast quantitative myocardial tissue characterization using Cardiac Magnetic Resonance Imaging (CMR) techniques
Follow-up
Participants are monitored for safety and effectiveness after imaging
What Are the Treatments Tested in This Trial?
Interventions
- Cardiac Magnetic Resonance (CMR) imaging techniques
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor